Evidence map›Paper›PMID 23598844›Full record

ArticleJournal of oncology practice2012

Clinical practice guidelines for cancer care: utilization and expectations of the practicing oncologist.

Melissa Dillmon, John M Goldberg, Suresh S Ramalingam, Robert J Mayer, Patrick Loehrer, Catherine Van Poznak

Abstract read
In one paragraph

Article in Journal of oncology practice, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Trends in Female Representation on NCCN Guideline Panels.Journal of the National Comprehensive Cancer Network : JNCCN · 2020
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Melissa DillmonHarbin Clinic, Rome, GA, USA. mdillmon@harbinclinic.com
John M Goldberg
Suresh S Ramalingam
Robert J Mayer
Patrick Loehrer
Catherine Van Poznak

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ASCO produces guidelines for oncologists, utilizing a systematic review process. Although this resource-intense process results in authoritative and widely cited guidelines, they can cover only a few specific clinical issues. Hence, the ASCO guidelines presently do not fully address many clinical situations. Expanding the scope of ASCO guidelines will require major revisions to the guidelines development process. Changes likely to improve the process include establishing disease-specific committees composed of content experts, improving methods to resolve conflicts of interest, simplifying steps to engage members to suggest topics for new guidelines, and linking guidelines utilization with quality indices. In a time of rapid change in practice and research in cancer, ASCO can play a pivotal role in patient care through major revisions to guideline development, accessibility, and integration with quality metrics.

Indexed as

Attitude of Health PersonnelAlgorithmsEvidence-Based MedicineGuideline AdherenceHumansMedical OncologyPractice Guidelines as TopicSocieties, MedicalUnited States

Identifiers

PMID23598844
PMCPMC3500479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.